Physician profile
Walter E Mashman
NPI 1639174840
$530.23
in general payments reported to CMS, 2019-2025
13 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $67.65 · 2021: $14.55 · 2022: $134 · 2023: $42.86 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $174.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $106.93 | 2020-2023 | Acuson Sc2000 Diagnostic Ultrasound System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $70.01 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $67.89 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $52.25 | 2022-2025 | Camzyos |
| Amgen INC. | $50.83 | 2025 | Repatha |
| Bracco Diagnostics INC. | $37.65 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.42 | 2021-2023 | Jardiance |
| Lantheus Medical Imaging, INC. | $27.02 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $24.64 | 2019 | |
| Kadmon Pharmaceuticals LLC | $21.35 | 2020 | |
| Novo Nordisk INC | $16.03 | 2025 | Wegovy |
| Pfizer INC. | $14.75 | 2019 | |
| Boston Scientific Corporation | $11.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Mashman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.